| Trade name of the product: |
| Taiverb |
| Pharmaceutical active ingredients: |
| Lapatinib Ditosylate Monohydrate |
| Available forms, composition and doses of Taiverb: |
| Tablets, Film-Coated; Oral; Lapatinib Ditosylate Monohydrate 250 mg / ml |
| Medical categories: |
| Human:Cytotoxic chemotherapy |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| L01XE07 - Lapatinib |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| GlaxoSmithKline |